Home
NICE Guidance
Published Guidance

Daratumumab with bortezomib and dexamethasone for previously treated multiple myeloma

Technology appraisal guidance [TA573] Published: 10 April 2019

Guidance

This guidance has been updated and replaced by NICE technology appraisal guidance 897.